| abstract |
Provided are a protein ubiquitination inhibitor and a fibrosis therapeutic agent. A protein ubiquitination inhibitor comprising at least one selected from the group consisting of plumbagin and quercetin, a salt thereof or a hydrate thereof, and plumbagin, a pharmaceutically acceptable salt thereof, or a salt thereof A therapeutic agent for fibrosis including a hydrate is provided. [Selection figure] None |